Exact Sciences
EXAS
#1150
Rank
ยฃ14.36 B
Marketcap
ยฃ75.68
Share price
-0.10%
Change (1 day)
59.35%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): -ยฃ4.22

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -ยฃ3.97. In 2024 the company made an earnings per share (EPS) of -ยฃ4.15.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ4.221.64%
2024-ยฃ4.15
2022-ยฃ2.642.31%
2021-ยฃ2.58-38.54%
2020-ยฃ4.20692.96%
2019-ยฃ0.53-50.69%
2018-ยฃ1.0744%
2017-ยฃ0.75-39.39%
2016-ยฃ1.23-2.94%
2015-ยฃ1.2737.1%
2014-ยฃ0.9279.71%
2013-ยฃ0.51-21.59%
2012-ยฃ0.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Myriad Genetics
MYGN
-ยฃ3.23-18.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
ยฃ0.25-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Veracyte
VCYT
ยฃ0.29-107.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-ยฃ37.95 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ2.76-169.66%๐Ÿ‡ซ๐Ÿ‡ท France